Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Genital Herpes Simplex Type 2”

8 trials

Showing 8 of 8 results

Testing effectiveness (Phase 2)Study completedNCT06033261
What this trial is testing

MRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

Who this might be right for
Genital Herpes
ModernaTX, Inc. 365
Early research (Phase 1)Study completedNCT00274300
What this trial is testing

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

Who this might be right for
HSV-2
PowderMed 36
Early research (Phase 1)Active Not RecruitingNCT05432583
What this trial is testing

A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

Who this might be right for
Genital Herpes Simplex Type 2
BioNTech SE 318
Early research (Phase 1)Active Not RecruitingNCT06385327
What this trial is testing

Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 115
Early research (Phase 1)UnknownNCT05393440
What this trial is testing

First-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Zhongnan Hospital 18
Early research (Phase 1)Active Not RecruitingNCT06698575
What this trial is testing

Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 146
Not applicableStudy completedNCT00803543
What this trial is testing

Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding

Who this might be right for
HIVHIV Infections
University of Alabama at Birmingham 103
Testing effectiveness (Phase 2)Study completedNCT01687595
What this trial is testing

Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes

Who this might be right for
Herpes Simplex Type 2
Agenus Inc. 80

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation